Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Sanofi

Sanofi

ADVERTISEMENT
News and Trends

Dupixent gets EU nod for children with severe atopic dermatitis

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive…

By Jim Cornall
January 27, 2023 - 4 minutes
News and Trends

CytoReason expands deal with Sanofi to look at IBD

CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…

By Jim Cornall
January 24, 2023 - 2 minutes
News and Trends

Positive Dupixent eosinophilic esophagitis phase 3 results

The New England Journal of Medicine has published results from a positive phase 3 trial…

By Jim Cornall
December 22, 2022 - 4 minutes
News and Trends

Sanofi and Innate Pharma expand natural killer cell deal

Sanofi and Innate Pharma SA have expanded their collaboration, with Sanofi licensing a natural killer (NK)…

By Jim Cornall
December 19, 2022 - 3 minutes
News and Trends

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European…

By Jim Cornall
December 15, 2022 - 5 minutes
News and Trends

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…

By Liza Laws
December 7, 2022 - 3 minutes
News and Trends

FDA clears insulin pen medical device

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices,…

By Jim Cornall
December 7, 2022 - 2 minutes
News and Trends

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position…

By Jim Cornall
November 30, 2022 - 3 minutes
News and Trends

Sanofi’s Enjaymo for hemolytic anemia given marketing authorization by EC

Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…

By Liza Laws
November 18, 2022 - 4 minutes
Interview

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…

By Jim Cornall
November 14, 2022 - 9 minutes
News and Trends

Prurigo nodularis treatment recommended for EU approval  

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…

By Jim Cornall
November 11, 2022 - 3 minutes
News and Trends

Sanofi and GSK Covid-19 booster vaccine approved by European Commission

Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines…

By Jim Cornall
November 10, 2022 - 2 minutes
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days